BuPROPion HCL Tablets, USP, 75 mg, packaged as UD 100 tablets (10x10), Rx Only, Mfg by: Sandoz Inc., 508 Carnegie Center, Suite 400, Princeton, NJ 08805, NDC: 63739-706-10
Published July 5, 2017 · Recall initiated: May 30, 2017
Summary
FDA records drug Class III recall D-0928-2017, published July 5, 2017 and initiated May 30, 2017. Recalling firm: Mckesson Packaging Services; Status: Terminated; Reported quantity: 942 cartons; Lot: Lot # 0113148, 0113149, 0113150, Exp: 04/18; 0113636, Exp: 06/18; 0114513, Exp: 10/18. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Moisture Limits: Product tested out-of-specification for moisture content.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Mckesson Packaging Services
- Distributor
- Nationwide in the US
- Lot
- Lot # 0113148, 0113149, 0113150, Exp: 04/18; 0113636, Exp: 06/18; 0114513, Exp: 10/18
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADiltiazem HCl Extended-Release Capsules, USP 240 mg, 100-count bottles, Rx Only, Mfg. By: Par PharmaceuticalMay 2, 2018
- FDADiltiazem HCl Extended-Release Capsules, USP 120 mg, 100-count bottles, Rx only, Mfg. By: Par PharmaceuticalMay 2, 2018
- FDADiltiazem CD (Diltiazem Hydrochloride Extended-Release Capsules, USP) 180 mg, 100-count bottles, Rx Only Mfg.May 2, 2018
- FDARANITIDINE Tablets, USP 150 mg UD 100 tablets (10x10), RX Only, Manufactured by: Amneal Pharmaceuticals,March 14, 2018
- FDADoxycycline Hyclate USP, active pharmaceutical ingredient, a) 25 g packaged in a 500 cc container (NDC:July 5, 2017
- FDABlephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 gJuly 5, 2017
Questions about this recall
Was BuPROPion HCL Tablets, USP, 75 mg, packaged as UD 100 tablets (10x10), Rx Only, Mfg by: Sandoz Inc., 508 Carnegie Center, Suite 400, Princeton, NJ 08805, NDC: 63739-706-10 recalled?
Yes. FDA published recall D-0928-2017 on July 5, 2017. Reported hazard: Failed Moisture Limits: Product tested out-of-specification for moisture content.
What should I do if I have this product?
Voluntary: Firm initiated · Letter